Recursion Pharmaceuticals R&D per Employee

R&D Spending per Employee of Recursion Pharmaceuticals is 850,540.00 USD in 2026.

R&D Spending per Employee of Recursion Pharmaceuticals changed from 628,842.00 USD to 850,540.00 USD, representing a 35.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Recursion Pharmaceuticals historically and in real time.